Diaceutics PLC (AIM: DXRX), announces the resignation of Julie Goonewardene as Non-Executive Chair. Julie will step down on 31 December 2020. Having been with Diaceutics for almost 10 years Julie has, with the support of the Board, decided to step down.
Julie Goonewardene commented: “It has been my pleasure and privilege to work with the Diaceutics team for the better part of a decade. I have enjoyed the journey of helping guide the Company from a small Irish boutique consultancy to a global publicly traded data enabled platform firm. My goal has always been to see the Company reach the important milestone of launching its transformative platform, DXRX, and together we have achieved this objective. DXRX has great potential and I look forward to seeing how it transforms the diagnostics industry.”
Peter Keeling, Chief Executive Officer of Diaceutics said: “Julie has been a trusted partner and friend through all of the growth stages of the Company and a key contributor to our most successful strategies right up to the successful IPO in March 2019. On behalf of the Board, we would like to thank Julie for all her hard work and the support she has given us during her time with Diaceutics. She has been a valued member of the Group, and we are sad to see her go.”